Cargando…
Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy
BACKGROUND: Multidrug resistance (MDR) is one of the major problems in the treatment of cancer. Overcoming it is therefore expected to improve clinical outcomes for cancer patients. MDR is usually characterized by overexpression of ABC (ATP-binding cassette) protein transporters such as P-gp, MRP1,...
Autores principales: | Huang, Limin, Perrault, Christelle, Coelho-Martins, Jennifer, Hu, Chaoquan, Dulong, Charlène, Varna, Mariana, Liu, Jielin, Jin, Jian, Soria, Claudine, Cazin, Lionel, Janin, Anne, Li, Hong, Varin, Rémi, Lu, He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717049/ https://www.ncbi.nlm.nih.gov/pubmed/23837843 http://dx.doi.org/10.1186/1756-8722-6-49 |
Ejemplares similares
-
Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib
por: Huang, Limin, et al.
Publicado: (2014) -
Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines
por: Gest, Caroline, et al.
Publicado: (2013) -
Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells
por: HUANG, LIMIN, et al.
Publicado: (2015) -
Comparative study of the effect of rivaroxaban and fondaparinux on monocyte’s coagulant activity and cytokine release
por: Laurent, Marc, et al.
Publicado: (2014) -
Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells
por: Hu, Chaoquan, et al.
Publicado: (2012)